MAUI, Hawaii & IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in the diagnosis of melanoma, hosted a MelaFind® workshop during the 10th Annual Maui Derm Conference in Hawaii. The conference seeks to increase physicians’ knowledge of developments in medical and cosmetic dermatology. Dr. Monica Scheel, a Board Certified Dermatologist based in Hawaii, hosted the MelaFind® workshop which reviewed the clinical use and benefits of the device as well as future technology development opportunities for the device and its underlying optical imaging and data analysis technology. Dr....
↧